EMD 7.32% 4.4¢ emyria limited

An MDMA analogue which could end up in direct competition with...

  1. 1,519 Posts.
    lightbulb Created with Sketch. 506
    An MDMA analogue which could end up in direct competition with Emyria's own ones. Very strange.

    All to generate some professional fees. Emeryia has changed so much from a promising biotech to a clinical service provider.
    Last edited by reon1: 20/06/24
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.003(7.32%)
Mkt cap ! $17.99M
Open High Low Value Volume
4.2¢ 4.4¢ 4.2¢ $1.778K 41.43K

Buyers (Bids)

No. Vol. Price($)
1 14900 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 125000 2
View Market Depth
Last trade - 12.05pm 13/09/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.